Background. Advanced glycation end products (AGEs) accumulate in patients with end-stage renal disease (ESRD). The aim of this study was to investigate the potential influence of different modalities of renal replacement therapies on plasma AGE levels. Methods. The removal of AGEs by high-flux haemodialysis (HD) using standard and ultrapure dialysis fluid (SDF and UDF), by haemodiafiltration (HDF) and by haemofiltration (HF) was studied by fluorescence spectroscopy and by a carboxymethyllysine (CML)-specific ELISA. In addition, molecular weight distribution of fluorescent AGE products in serum of several patients was analysed by gel filtration. Results. The highest AGE-typical fluorescence was found in the serum of patients on HD using SDF (114 667"18 967 arbitrary units (AU)), followed by patients on HDF (86 912"24 411 AU, P-0.005), by patients on HD using UDF (74 953"21 152 AU, P-0.0001) and by patients on HF (74 039" 17 027 AU, P-0.0001). Similar results were found for serum CML levels with the highest values in HD patients on SDF (1609"504 nguml), followed by patients on HF (1354"614 nguml, P-0.001), then by HD patients on UDF (1310"403 nguml, P-0.001) and by patients on HDF (1132"338 nguml, P-0.001). The removal rate of AGEs, as evaluated by the determination of the pre-upost-dialysis AGE differences, was comparable across all groups. Conclusion. These findings suggest that factors other than removal are responsible for the lower pre-dialysis AGE levels found in patients on convective dialysis as well as on HD with UDF. A role of water quality is assumed. This is corroborated by the finding that the high molecular weight AGE-fraction is preferentially lowered in comparison with patients on HD with SDF, as analysed by gel filtration chromatography. These findings could be best explained by a less severe oxidative stress (i.e. resulting in decreased AGE generation) with HF and HDF, as well as with ultrapure HD.
Introduction
Advanced glycation end products (AGEs) are thought to be involved in many complications of diabetes as well as those of end-stage renal failure [1] [2] [3] . These compounds are formed by a non-enzymatic reaction between reducing sugars or other reactive glycation products and primary amino groups of proteins. They form a structurally diverse class of heterocyclic molecules which exhibit fluorescence, cross-linking properties and have a yellow-brown colour [4] .
Patients with end-stage renal disease (ESRD) have very high AGE levels [5] [6] [7] . The main factors involved are increased AGE formation by enhanced carbonyl and oxidative stress, and impaired AGE removal by the damaged kidney [8] . In ESRD, dialysis therapy may contribute to the removal of AGEs, particularly AGE peptides [6] . It is therefore of interest to investigate the influence of different modalities of renal replacement therapies. In this study, the removal of AGEs by high-flux haemodialysis (HD) using standard dialysis fluid (SDF) and ultrapure dialysis fluid (UDF), by haemodiafiltration (HDF) and by haemofiltration (HF) was examined by fluorescence spectroscopy and by an enzyme-linked immunosorbent assay (ELISA); in addition, the molecular weight distribution of fluorescent AGE-products in the serum of several patients was analysed by gel filtration chromatography.
Patients and methods
This cross-sectional study was performed in 71 stable dialysis patients with long-term ESRD. Four patient groups were formed: patients on haemodialysis with SDF (ns18), HD patients with UDF (ns17), patients on HDF (ns18) and patients on HF (ns18). Main patient characteristics are given in Table 1 . Residual function was -100 ml urineu24 h. GFR was therefore not determined. Eleven healthy subjects served as controls.
Dialysis treatment modalities
In all patients, three dialysis sessions per week for ;4.5 h took place. The adequacy of dialysis was measured by urea reduction ratio ()65%) and KtuV ()1.2) values. No dialyser was re-used.
Maintenance HD was performed as follows: blood flow 250-300 mlumin, dialysate flow rate 500 mlumin. Dialysers were high-flux polysulfone dialysers (F 60S or HF 80S; Fresenius Medical Care, Bad Homburg, Germany). Standard dialysis fluid was prepared from purified water obtained from reverse osmosis and mixed with the acid electrolyte concentrate (SKF213 with a potassium content of 2.0 mValul or SKF313 with a potassium content of 3.0 mValul; Fresenius Medical Care) and the liquid bicarbonate solution obtained from NaCO 3 powder (Bilog; Fresenius Medical Care).
Microbial contamination of SDF was determined monthly in the dialysate at temperatures of 228C and 368C for a prolonged incubation time of 7 days. All bacterial counts were in the range of 0-70 colony-forming units (CFU)uml and thus met the standards of the Association for the Advancement of Medical Instrumentation (O200 CFUuml in water, 2000 CFUuml in dialysate). The endotoxin level in the dialysate was measured by the limulus amoebocyte lysate (LAL) assay. Our data was markedly less than the limit of 0.25 endotoxin units (EU)uml.
UDF was achieved by placing an additional ultrafilter (polysulfone, 0.1 mm) close to the dialyser. UDF is characterized by a bacterial contamination of -0.1 CFUuml and unmeasurable endotoxin levels (-0.03 EUuml) [9] , which is in line with our data.
Post-dilution haemodiafiltration (HDF) was performed using AK 200 machines (Gambro, Hechingen) as well as a specially equipped Fresenius 4008 machine. Haemodiafilters were HF60 and HF80, depending on the body surface. Ultrapure water was used both for the dialysate and for online production of the highly purified substitution fluid. Blood flow averaged 300-350 mlumin, total dialysate flow 650 mlumin, dialysate flow 500-550 mlumin, infusate flow ;100 mlumin. Total filtrate volume was aimed at one-third of the body weight, corresponding to 20-25 l per session.
Online HDF (post-dilutional method) was performed by use of AK 200 ULTRA machines (Gambro), as well as Online PLUS 4008 machines from Fresenius. Haemodiafilters were HF60 and HF80, depending on the body surface. Ultrapure water was used both for the dialysate and for online production of the highly purified substitution fluid. Blood flow averaged 300-350 mlumin, total dialysate flow 650 mlumin, dialysate flow 500-550 mlumin, infusate flow ;100 mlumin. Total filtrate volume was aimed at one-third of the body weight, corresponding to 23-27 l per session.
In a similar manner, post-dilutional haemofiltration (HF) was performed using AK 200 ULTRA machines, and HF60 and HF80 haemofilters. Total fluid exchange was identical to that of HDF.
Blood sampling
After receiving informed consent, blood samples of the patients were collected at midweek and endweek sessions before (prior to heparin administration) and after the therapy session (-5 min). Samples were collected into Sarstedt monovettes, centrifuged for 10 min and the serum stored at À208C before determination.
Fluorescence spectroscopy
The fluorescence measurement of the 50-fold diluted serum samples (corrected for background) was performed in triplicate on a FluoroMax spectrometer (Spex Instruments, Edison, NJ, USA) at a wavelength of 440 nm (excitation 370 nm) as described previously [10] . Haemolytic sera were excluded. No significant shift of the fluorescence maximum was observed after dialysis.
Measuring the content of Ne-(carboxymethyl)lysine (CML) by competitive ELISA Serum CML concentrations were measured in triplicate by a competitive ELISA developed by ROCHE Diagnostics (Penzberg, Germany) using the anti-CML monoclonal antibody 4G9 (Alteon Inc., New York, NY, USA) as described previously [11] . Briefly, Proteinase-K-digested serum (to make hidden epitopes accessible) was incubated on AGE-BSA-coated, BSA-blocked microtitre plates in the presence of peroxidase-conjugated anti-CML monoclonal antibody for 1 h. After three washing steps, colour reaction was induced with 2,29-azino-di-3-ethylbenzthiazoline-sulfonic acid (Roche Diagnostics) and 0.01% H 2 O 2 in 0.01% glycineucitrate buffer and absorbance was read in a microtitre ELISA plate reader (Multiskan Ascent; Labsystems, Helsinki, Finland) at 405 nm. All steps were carried out at room temperature. N-(carboxymethyl-)amino-caproic acid (Alteon Inc.) served as standard. 
Statistics
Results are expressed as mean"SD. Comparison between different groups was performed by one-way analysis of variance (ANOVA) using the SPSS program package (SPSS Inc., Chicago, IL, USA). Statistical significance was defined at P-0.05.
Results

Fluorescence measurements
When AGE levels in serum of controls (ns11) were compared with serum AGE levels of dialysis patients, a significant difference was found (P-0.0001) between control and all treatment modalities (Figure 1 ). Figure 1 shows that there are also differences in AGE levels in the serum of dialysis patients on different therapy forms. The highest fluorescence at predialysis was found in serum of HD patients using SDF, followed by patients on HDF and HF (Table 2) . Fluorescence levels of patients on HD using UDF were found in the same range as for patients on HF ( Table 2 ). The level of AGE-typical fluorescence of the HDF patients and HF patients was ;24% (P-0.005) and ;35% (P-0.0001) lower, respectively, than that of patients on HD with SDF. The use of UDF lowered serum fluorescence by 35% (P-0.005). The differences were not significant between HDF and HD with UDF, between HF and HD with UDF, or between HDF and HF. In the course of a dialysis session, the serum levels of AGE-typical fluorescence declined by 24% (HD with UDF, P-0.001), 28% (HD with SDF, P-0.001), 35% (HF, P-0.001) and 23% (HDF, P-0.001) (corrected for haemo-concentration according to Bergstrom and Wehle [12] ) ( Table 3 ). The differences in the reduction rate of the AGE-typical fluorescence were not significant. The post-dialysis AGE-typical fluorescence levels of HF and HDF were significantly lower than those of HD patients on SDF (P-0.001).
AGE levels in serum measured by competitive ELISA
In accordance with the fluorescence measurements, the ELISA of CML showed a significant difference between dialysis patients and controls (P-0.0001) for all three renal replacement therapies (Figure 1) . Also, significantly lower CML levels were observed for patients on HDF and HF (P-0.001) when compared with HD patients with SDF. CML levels of patients on HD with UDF were found to be intermediate, being significantly lower than levels of patients on HD with SDF, but having slightly higher levels of CML compared with HDF (P)0.1, not significant) ( Table 2) . The differences between HD with UDF and HF as well as HDF vs HF were not significant. Serum CML values of HF patients were slightly higher (1354"614 nguml) than those of HDF patients (1132"338 nguml) (P-0.1). The average reduction of CML within one dialysis session was 28% (P-0.001) for HD with SDF, 28% (P-0.001) for HD with UDF, 32% (P-0.001) for HDF and 31% (P-0.001) for HF. There was no significant difference between the different dialysis modalities with respect to CML reduction (Table 3) .
Gel filtration chromatography
Molecular weight distribution of serum AGEs was determined by gel filtration chromatography on a Superdex column (separation range 3-70 kDa). Serum samples of five patients of each subgroup (SDF HD, UDF HD, HDF, HF) were analysed and compared with controls ( Figure 2 ). While differences in serum fluorescence between HD patients and controls are due to considerably higher levels of both the high-(MW )12 kDa) and low-molecular weight (MW -12 kDa) fluorescent AGEs, the dissimilarity in overall fluorescent AGE concentrations of the patients on different dialysis modalities appears to be mainly due to a lower AGE modification of proteins, in particular albumin, as judged from the quantification of the gel filtration chromatograms (Table 4) .
Discussion
In various studies it has been demonstrated that removal of AGEs by dialysis is inadequate, mostly due to the fact that the majority of AGEs are proteinbound. Thus, only small percentages of total pentosidine can be removed by dialysis [13] . In the case of CML and fluorescent AGEs, higher reduction rates in the range of 20% were reported [14, 15] . Furthermore, it could be shown that the chemical nature of the dialysis membranes may have a higher impact on AGE levels than the pore size [16] , giving rise to the suspicion that AGE generation by polymers may override their removal capacity. The original intention of this study Fig. 2 . Comparison of molecular weight distribution of AGEs in serum of selected patients (ns3) on high-flux haemodialysis using standard (grey curve) or ultrapure dialysis fluid (black curve) and of healthy controls (dashed curve) (A) and on high-flux haemodialysis using ultrapure dialysis fluid (black curve) and haemodiafiltration (grey curve) and of healthy controls (dotted curve) (B). Serum samples were diluted 1 : 2 with PBS and 100 ml were loaded onto a gel filtration column with a flow rate of 1 mlumin (Superdex 75 HR 10u30, Pharmacia), AGEs were monitored by fluorescence (excitation 370 nm, emission 440 nm). was to show whether-apart from pore size and chemical nature of membranes-dialysis modalities such as haemofiltration and haemodiafiltration can influence serum AGE levels, since the latter treatment modalities have been reported to remove peptides more efficiently than high-flux dialysis [17] . At first glance, in agreement with these findings, we found that the pre-dialysis AGE levels of patients on haemodiafiltration and haemofiltration are significantly lower than those of patients on high-flux haemodialysis using standard dialysis fluid. An effect of the chemical nature of the membranes is unlikely, since only polysulfone membranes were used. However, no significant difference in AGE removal rate could be found for haemodialysis and haemofiltrationuhaemodiafiltration. Therefore, the lower pre-dialysis AGE levels of patients on HDF and HF cannot be easily explained by more efficient removal during therapy session, although long-term effects of small, immeasurable differences cannot be excluded. Another possible source of raised AGE serum levels can be increased formation. Miyata and colleagues (2000) have found that there is considerably enhanced carbonyl and oxidative stress in dialysis patients, which might contribute substantially to the heightened levels of AGEs [8] .
Hence, less oxidative stress may be present in patients on haemodiafiltration and haemofiltration compared with high-flux haemodialysis (using SDF), although the same dialysis membranes are used in all modalities. This is corroborated by the fact that the concentration of high molecular weight AGEs-in particular albumin-bound AGEs-is lowered in HF and HDF. This cannot be achieved by removal of AGEs but may be better explained by a more efficient removal of AGE precursors such as dicarbonyls, oxidants and free radicals, leading to reduced AGE generation. An important factor to be discussed as a possible promotor of oxidative stress is the quality of dialysis fluid. Water containing pyrogens may stimulate proinflammatory processes, as seen by increased levels of pro-inflammatory cytokines and acute phase proteins [9] . Even a low-grade bacterial contamination of the dialysate (-200 CFUuml) may exert toxic effects with increased release of radicals and cytokine formation from the mononuclear cells (the so-called cytokineinducing substances) [9] . Naturally, for haemofiltration and haemodiafiltration, only sterile and double-filtered pyrogen-free substitution fluid is used. Apart from convective transport, another important difference between haemodiafiltration and haemodialysis with SDF is the use of ultrapure dialysis fluid as well as highly purified sterile infusions. To test the role of water quality, AGE levels of haemodialysis patients using standard or ultrapure dialysis fluids were compared. The results suggest an influence of water quality on AGE levels, although the bacterial counts in the HD patients on standard dialysis met with criteria of the Association for the Advancement of Medical Instrumentation (Figures 1 and 2) . Also, the LAL test was within normal limits.
According to our studies, we assume that in the case of AGE-typical fluorescence, water purity of the dialysate anduor of the infusion fluid may account at least partially for the observed reduction in pre-dialysis AGE levels of patients on haemofiltration or haemodiafiltration. Our results indicate that, besides many other potential factors (e.g. residual renal function, membrane properties, oxygen radical formation and nutritional factors), water quality appears to have an impact on serum AGE levels of dialysis patients as well.
